{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:02:59Z","timestamp":1762264979170,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001320","name":"Wolfson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.neurobiolaging.2009.02.007","type":"journal-article","created":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T04:22:49Z","timestamp":1236918169000},"page":"272-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background"],"prefix":"10.1016","volume":"32","author":[{"given":"Aviva","family":"Katzav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achinoam","family":"Faust-Socher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Kvapil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"Michaelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miri","family":"Blank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaim G.","family":"Pick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos D.","family":"Korczyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joab","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0002-9343(89)90335-5","article-title":"Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome","volume":"86","author":"Asherson","year":"1989","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib2","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1172\/JCI115749","article-title":"Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)","volume":"89","author":"Bakimer","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1196\/annals.1398.053","article-title":"Identification of histidine-rich glycoprotein, a potential autoantigen, in human and rat brain preparations","volume":"1109","author":"Ball-Rosen","year":"2007","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0197-4580(99)00110-4","article-title":"Vascular risk factors for Alzheimer's disease: an epidemiologic perspective","volume":"21","author":"Breteler","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib5","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1191\/0961203303lu390oa","article-title":"Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002","volume":"12","author":"Brey","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-510X(98)00027-6","article-title":"Anti-beta 2-glycoprotein I antibodies bind to central nervous system","volume":"156","author":"Caronti","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-510X(02)00271-X","article-title":"Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants","volume":"203\u2013204","author":"Chapman","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1191\/096120399678847524","article-title":"Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes","volume":"8","author":"Chapman","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1191\/0961203303lu392oa","article-title":"Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies","volume":"12","author":"Chapman","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/6374","article-title":"Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice","volume":"2","author":"Chapman","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib12","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0896-6273(95)90107-8","article-title":"Age-related CNS disorder and early death in transgenic FVB\/N mice overexpressing Alzheimer amyloid precursor proteins","volume":"15","author":"Hsiao","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbr.2006.01.015","article-title":"Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome","volume":"169","author":"Katzav","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1191\/096120301678416060","article-title":"Hyperactivity in a mouse model of the antiphospholipid syndrome","volume":"10","author":"Katzav","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0031-9384(02)00639-X","article-title":"Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months","volume":"75","author":"King","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000017211","article-title":"Dementia and antiphospholipid antibodies","volume":"11","author":"Mosek","year":"2000","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0020-711X(80)90229-3","article-title":"Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions","volume":"11","author":"Polz","year":"1980","journal-title":"Int. J. Biochem."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.282.5391.1079","article-title":"Genetic neurodegenerative diseases: the human illness and transgenic models","volume":"282","author":"Price","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(05)63936-0","article-title":"From antiphospholipid syndrome to antibody-mediated thrombosis","volume":"350","author":"Roubey","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1568-9972(01)00005-2","article-title":"Hughes syndrome crosses boundaries","volume":"1","author":"Ruiz-Irastorza","year":"2002","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1191\/0961203302lu255oa","article-title":"Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies","volume":"11","author":"Shrot","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","article-title":"Brain infarction and the clinical expression of Alzheimer disease. The Nun Study","volume":"277","author":"Snowdon","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nbd.2007.12.004","article-title":"Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome","volume":"30","author":"Tanne","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib24","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1001\/archinte.166.20.2278","article-title":"Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings","volume":"166","author":"Tektonidou","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib25","first-page":"937","article-title":"The role of amyloid in the pathogenesis of Alzheimer's disease","volume":"378","author":"Verbeek","year":"1997","journal-title":"Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib26","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","article-title":"The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease","volume":"22","author":"Westerman","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2009.02.007_bib27","first-page":"67","article-title":"Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model","volume":"11","author":"Ziporen","year":"2004","journal-title":"Clin. Dev. Immunol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458009000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458009000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:58:27Z","timestamp":1762264707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458009000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0197458009000414"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.02.007","relation":{},"ISSN":["0197-4580"],"issn-type":[{"type":"print","value":"0197-4580"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}